Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberta Reniè

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Journal of the American Medical Directors Association|November 24, 2015
Sociodemographic and Clinical Changes Over Time of Individuals Evaluated for Cognitive Disturbances: Good or Bad News?Marco Canevelli, Matteo Cesari, Federico Trobia, et al.
Frontiers in Neurology|March 31, 2022
Late-Onset MS: Disease Course and Safety-Efficacy of DMTSMaria Chiara Buscarinu, Roberta Reniè, Emanuele Morena, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 9, 2024
Disentangling multiple sclerosis phenotypes through Mendelian disorders: A network approachGianmarco Bellucci, Maria Chiara Buscarinu, Roberta Reniè, et al.
Microorganisms|July 27, 2024
Gut Microbiota Composition Is Causally Linked to Multiple Sclerosis: A Mendelian Randomization AnalysisValeria Zancan, Martina Nasello, Rachele Bigi, et al.
Brain Sciences|November 2, 2019
Autoimmune Encephalitis and CSF Anti-GluR3 Antibodies in an MS Patient after Alemtuzumab TreatmentMaria Chiara Buscarinu, Arianna Fornasiero, Giulia Pellicciari, et al.
Microorganisms|June 2, 2021
MAIT Cells and Microbiota in Multiple Sclerosis and Other Autoimmune DiseasesRosella Mechelli, Silvia Romano, Carmela Romano, et al.
Multiple Sclerosis and Related Disorders|May 27, 2025
Influence of oral and skin microbiota on multiple sclerosis risk and severity: A mendelian randomization analysisValeria Zancan, Martina Nasello, Selene Diamant, et al.
International Journal of Molecular Sciences|May 25, 2024
Clinical and Immunological Impact of Ocrelizumab Extended Interval Dosing in Multiple Sclerosis: A Single-Center, Real-World ExperienceMartina Nasello, Valeria Zancan, Virginia Rinaldi, et al.
Frontiers in Neurology|December 19, 2022
CNS inflammatory demyelinating events after COVID-19 vaccines: A case series and systematic reviewVirginia Rinaldi, Gianmarco Bellucci, Maria Chiara Buscarinu, et al.
Frontiers in Immunology|October 14, 2021
Multiple Sclerosis and SARS-CoV-2: Has the Interplay Started?Gianmarco Bellucci, Virginia Rinaldi, Maria Chiara Buscarinu, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of the American Medical Directors Association|November 24, 2015
Sociodemographic and Clinical Changes Over Time of Individuals Evaluated for Cognitive Disturbances: Good or Bad News?Marco Canevelli, Matteo Cesari, Federico Trobia, et al.
Frontiers in Neurology|March 31, 2022
Late-Onset MS: Disease Course and Safety-Efficacy of DMTSMaria Chiara Buscarinu, Roberta Reniè, Emanuele Morena, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 9, 2024
Disentangling multiple sclerosis phenotypes through Mendelian disorders: A network approachGianmarco Bellucci, Maria Chiara Buscarinu, Roberta Reniè, et al.
Microorganisms|July 27, 2024
Gut Microbiota Composition Is Causally Linked to Multiple Sclerosis: A Mendelian Randomization AnalysisValeria Zancan, Martina Nasello, Rachele Bigi, et al.
Brain Sciences|November 2, 2019
Autoimmune Encephalitis and CSF Anti-GluR3 Antibodies in an MS Patient after Alemtuzumab TreatmentMaria Chiara Buscarinu, Arianna Fornasiero, Giulia Pellicciari, et al.
Microorganisms|June 2, 2021
MAIT Cells and Microbiota in Multiple Sclerosis and Other Autoimmune DiseasesRosella Mechelli, Silvia Romano, Carmela Romano, et al.
Multiple Sclerosis and Related Disorders|May 27, 2025
Influence of oral and skin microbiota on multiple sclerosis risk and severity: A mendelian randomization analysisValeria Zancan, Martina Nasello, Selene Diamant, et al.
International Journal of Molecular Sciences|May 25, 2024
Clinical and Immunological Impact of Ocrelizumab Extended Interval Dosing in Multiple Sclerosis: A Single-Center, Real-World ExperienceMartina Nasello, Valeria Zancan, Virginia Rinaldi, et al.
Frontiers in Neurology|December 19, 2022
CNS inflammatory demyelinating events after COVID-19 vaccines: A case series and systematic reviewVirginia Rinaldi, Gianmarco Bellucci, Maria Chiara Buscarinu, et al.
Frontiers in Immunology|October 14, 2021
Multiple Sclerosis and SARS-CoV-2: Has the Interplay Started?Gianmarco Bellucci, Virginia Rinaldi, Maria Chiara Buscarinu, et al.
Pageof 2